Ona Therapeutics, SL
Latest round
- Series B
Last raised
- Jun 2026
Total raised
- $120M
Investors
- 11
About Ona Therapeutics, SL
Ona Therapeutics is a biotechnology company focused on developing innovative antibody drug conjugates for advanced cancer treatments, particularly for patients with limited therapeutic options. Founded in 2019, Ona Therapeutics, SL is based in Barcelona, Spain, and specializes in developing therapeutics for oncology. The founders, Salvador Benitah and Valerie Vanhooren (CEO), have significant experience in the industry and lead the company's strategic initiatives. Ona Therapeutics specializes in the development of first-in-class antibody drug conjugates (ADCs) aimed at addressing the unmet medical needs of patients with advanced cancers, particularly those who have become refractory to existing treatments. The company’s pipeline includes innovative therapies, such as an undisclosed ADC targeting refractory breast cancer patients and another ADC for prevalent solid tumors. Additionally, Ona is developing a monoclonal antibody that targets CD36, a key metabolic regulator implicated in cancer progression. Their therapeutic solutions cater primarily to oncology practices and clinical institutions, focusing on North America and Europe. Ona Therapeutics generates revenue primarily through strategic partnerships and collaborations with academic institutions and clinical research organizations. Specific pricing structures for products are determined during the commercialization phase.
Who invested in Ona Therapeutics, SL
11 investors across 2 rounds
See all investors in Ona Therapeutics, SL
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ona Therapeutics, SL
Who invested in Ona Therapeutics, SL?
Ona Therapeutics, SL has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ona Therapeutics, SL raised?
Ona Therapeutics, SL has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ona Therapeutics, SL last raise money?
Ona Therapeutics, SL's most recent round on record is a Series B, in Jun 2026.
What does Ona Therapeutics, SL do?
Ona Therapeutics is a biotechnology company focused on developing innovative antibody drug conjugates for advanced cancer treatments, particularly for patients with limited therapeutic options.
Where is Ona Therapeutics, SL headquartered?
Ona Therapeutics, SL is headquartered in Barcelona, Spain.
Which VCs invest in companies like Ona Therapeutics, SL?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Ona Therapeutics, SL's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Ona Therapeutics, SL? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.